Much progress has been made on blood-based biomarkers for neurological diseases, though challenges in this field should be addressed before they are applied into clinical use.
Complete our short survey on biomarker discovery and development in neurological disorders and be the first to receive our infographic collated from the survey results.
Following the publication of the James Lind Alliance Priority Setting Partnership ‘Digital Technology for Mental Health’ top ten research priorities, this article, from the UK, considers the challenge of creating a truly user-driven approach to realize the promise of digital mental health.
Carissa Drake delves into sport-related concussions and their consequences, including the importance of social media on accurately reporting incidences.
The second and final installment of our discussion focuses on the use of stem cells and what further research is on the horizons for multiple sclerosis.
In the first installment of this discussion, our experts discuss the mechanisms, therapies and challenges involved in multiple sclerosis research.
We bring together Parkinson’s advances from across research and industry from the year so far.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.